Showing 2,021 - 2,040 results of 14,813 for search '(( significance ((set decrease) OR (mean decrease)) ) OR ( significant increase decrease ))', query time: 0.58s Refine Results
  1. 2021

    Fig 23 - by Zhezhe Zhang (19704587)

    Published 2024
    Subjects:
  2. 2022
  3. 2023
  4. 2024
  5. 2025

    Fig 19 - by Zhezhe Zhang (19704587)

    Published 2024
    Subjects:
  6. 2026

    Fig 8 - by Zhezhe Zhang (19704587)

    Published 2024
    Subjects:
  7. 2027
  8. 2028
  9. 2029

    Adverse event list. by Stefan Halbherr (21353882)

    Published 2025
    “…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”
  10. 2030

    Patient characteristics. by Stefan Halbherr (21353882)

    Published 2025
    “…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”
  11. 2031
  12. 2032
  13. 2033

    PRISMA flowchart of the included studies. by Gaelle Salame (21077899)

    Published 2025
    “…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …”
  14. 2034

    Characteristics of Included Studies. by Gaelle Salame (21077899)

    Published 2025
    “…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …”
  15. 2035
  16. 2036
  17. 2037
  18. 2038
  19. 2039
  20. 2040